Vanderbilt Transplant Center

Transcription

1 Vanderbilt Transplant Center General Information Contact Information Nonprofit Address Vanderbilt Transplant Center 805 Oxford House st Avenue South Nashville, TN Phone (615) Fax Web Site Web Site At A Glance Year of Incorporation

2 Mission & Impact Statements Mission Our Mission: To provide end-stage organ failure patients an opportunity to lead an extraordinary life. Our Vision: To provide the highest quality, most cost-effective, multidisciplinary care to the community of patients suffering from end-stage organ disease, lead advances in the care of these patients through innovative research, and train the next generation of tranplant physicians, nurses, pharmacists, and administrators. Background Vanderbilt Transplant Center is one of the south's premier providers of solid organ and stem cell transplantation. Located in Nashville, Tennessee, the Transplant Center is part of the Vanderbilt Medical Center and Vanderbilt University campus. Organized 26 years ago by Dr. William H. Frist, Vanderbilt Transplant Center is a fullservice, multidisciplinary transplant center specializing in heart, lung, liver, kidney, pancreas and stem cell transplantation. Vanderbilt Transplant Center recognizes the value of treating and supporting each transplant patient as a whole person. As such, Vanderbilt's doctors, nurses and staff have always focused not only on one aspect of transplantation but the whole process, from basic research to patient education. View a timeline of the Vanderbilt Transplant Center below: 1962 Vanderbilt performed its first kidney transplant and is one of the oldest, largest transplant programs in the U.S. To date, Vanderbilt has performed more than 4,000 adult and pediatric kidney transplants. 1985Vanderbilt performed the first pancreas transplant in Tennessee (February)Vanderbilt performed Tennessee's first pediatric heart transplant (April)Vanderbilt performed its first heart transplant. To date, Vanderbilt has performed more than 500 adult and pediatric heart transplants. 1987Vanderbilt performed the first successful combined heart/lung transplant in the Southeast. 1989William H. Frist, M.D. and J. Harold Helderman, M.D. founded the Vanderbilt Transplant Center as a full-service, multidisciplinary provider of transplantation. 1995The Vanderbilt Return-to-Work Program began helping transplant patients retrain for new vocational goals and obtain jobs. 2000Vanderbilt performed its first triple organ transplant of heart, lungs, and liver one of only eight performed worldwide. 2006Vanderbilt Transplant Center developed the Transplant Pharmacy Residency Program and the Transplant Administrator Specialty Program. 2007Kidney Transplant Program achieved 45-year milestone and surpassed 3,500 kidney transplants. 2008Vanderbilt performs first combined heart/kidney transplant. 2009Vanderbilt performs 1,000th liver transplant. 2010Berlin device (VAD) used for the first time in Tennessee by Vanderbilt Pediatric Heart Transplant Program. 2011Seth J. Karp, M.D. named Director, Vanderbilt Transplant Center. 2014Douglas W. Hanto, M.D., PhD, named Pediatric Liver Transplant Surgical Director and Director, Vanderbilt Transplant Center. Impact Accomplishments: Increased outreach to referring physicians thereby improving access for disadvantaged patients. Marked increase in utilization of Bridge to Transplant and Destination Therapy through Ventricular Assist Device Implantation New state of the art transplant unit catering to transplant patients Rollout of webbased online tool to screen potential living kidney donors to increase access to living donation. Goals: Increase organ availability through public outreach and education regarding donation. Improve patient throughput from evaluation to transplant for all transplant programs. Expand transplant-specific quality initiatives throughout inpatient and outpatient areas. Needs Optimize length of stay for donors by decreasing expected mean Length of Stay by 1 day from 3.5 to 2.5. Increase living kidney donation rates through expanded educational efforts and collaboration with Alliance for Paired Donation to increase kidney paired donation. Improve living kidney donor follow up and education during the first two years post donation. Increase efficiency of transplant center processes and reduce resource utilization in an effort for cost containment. Improved patient access for all organ programs. Service Categories Primary Organization Category Health Care / Organ & Tissue Banks 2

3 Areas of Service Areas Served TN - Davidson 3

4 Programs Programs Adult Solid Organ Transplant Programs Description Inclusive of: Kidney/Pancreas Transplant Liver Transplant Heart Transplant Lung Transplant Budget $13,382,453 Category Health Care, General/Other Inpatient/Hospital Care Population Served Adults,, Pediatric Solid Organ Transplant Programs Description Inclusive of: Kidney TransplantLiver Transplant Heart Transplant Budget $879,649 Category Health Care, General/Other Inpatient/Hospital Care Population Served Children and Youth (0-19 years),, 4

5 Governance Board Chair Board Chair Chairman Mark F. Dalton Company Affiliation BOT Chairman Term July 2011 to June 2017 Board Members Name Affiliation Status Mary Beth Adderley Emeritus/a Trustee NonVoting Michael L. Ainslie Emeritus/a Trustee NonVoting M. Chandler Anthony Member Voting William W. Bain Jr. Emeritus/a Trustee NonVoting Lee M. Bass Member Voting Darryl D. Berger Emeritus/a Trustee NonVoting Camilla Dietz Bergeron Emeritus/a Trustee NonVoting Adolpho A. Birch III Member Voting Dennis C. Bottorff Emeritus/a Trustee NonVoting Lewis M. Branscomb Emeritus/a Trustee NonVoting Shirley M. Collado Member Voting Thomas F. Cone Emeritus/a Trustee NonVoting Cecil D. Conlee Emeritus/a Trustee NonVoting Daniel M. Crown Member Voting Brownlee O. Currey Jr. Emeritus/a Trustee NonVoting Mark F. Dalton Chairman Voting Claiborne P. Deming Member Voting Charles H. Esserman Member Voting Bruce R. Evans Member Voting Frank A. Godchaux III Emeritus/a Trustee NonVoting John R. Hall Emeritus/a Trustee NonVoting L. Hall Hardaway Jr. Emeritus/a Trustee NonVoting H. Rodes Hart Emeritus/a Trustee NonVoting Joanne F. Hayes Emeritus/a Trustee NonVoting David W. Head Member Voting John J. Hindle Member Voting Jay C. Hoag Member Voting Martha R. Ingram Emeritus/a Trustee NonVoting John R. Ingram Member Voting Edith C. Johnson Secretary Voting Carroll E. Kimball Member Voting J. Hicks Lanier Emeritus/a Trustee NonVoting Rev. Edward A. Malloy CSC Emeritus/a Trustee NonVoting 5

6 Mark P. Mays Member Voting Jackson W. Moore Vice-Chairman Voting Edward G. Nelson Emeritus/a Trustee NonVoting Courtney C. Pastrick Member Voting David W. Patterson M.D. Member Voting Ross Perot Jr. Member Voting Kenneth L. Roberts Emeritus/a Trustee NonVoting Joe L. Roby Emeritus/a Trustee NonVoting Jeffrey J. Rothschild Member Voting Sidanth Sapru Member Voting Robert C. Schiff Jr, M.D. Member Voting Eugene B. Shanks Jr. Emeritus/a Trustee NonVoting Richard H. Sinkfield Emeritus/a Trustee NonVoting Alexander C. Taylor Member Voting Cal Turner Emeritus/a Trustee NonVoting J. Stephen Turner Member Voting Eugene H. Vaughan Emeritus/a Trustee NonVoting Thomas B. Walker Jr. Emeritus/a Trustee NonVoting Dudley B. White Emeritus/a Trustee NonVoting W. Ridley Wills II Emeritus/a Trustee NonVoting J. Lawrence Wilson Emeritus/a Trustee NonVoting Rebecca W. Wilson Emeritus/a Trustee NonVoting William M. Wilson Emeritus/a Trustee NonVoting Jon Winkelried Vice-Chairman Voting Nicholas S. Zeppos Chancellor of the University Voting Board Demographics - Ethnicity African American/Black 2 Asian American/Pacific Islander 2 Caucasian 22 Hispanic/Latino 1 Native American/American Indian 0 Other 0 Board Demographics - Gender Male 23 Female 4 Unspecified 0 Governance Board Term Lengths 6

7 Board Term Limits 2 Board Meeting Attendance % 90% 5 Written Board Selection Criteria? Written Conflict of Interest Policy? Percentage Making Monetary Contributions 100% Percentage Making In-Kind Contributions 100% Constituency Includes Client Representation Number of Full Board Meetings Annually 3 Board CoChair Board CoChair Vice-Chairman Jackson W. Moore Company Affiliation BOT Vice-Chairman Term July 2011 to June 2017 CEO Comments Board Selection Criteria Section: The Vanderbilt Transplant Center does not have a Board, but does fall under the Vanderbilt University Board of Trust. Conflict of Interest Policy: The Vanderbilt Transplant Center falls under the Vanderbilt University Medical Center's Conflict of Interest policy. 7

8 Management Executive Director/CEO Executive Director Edward Y. Zavala M.B.A. Term Start June Staff Full Time Staff 90 Part Time Staff 4 Volunteers 0 Contractors 0 Retention Rate 0% Plans & Policies Does the organization have a documented Fundraising Plan? Does the organization have an approved Strategic Plan? In case of a change in leadership, is a Management Succession plan in place? Does the organization have a Policies and Procedures Plan? Does the organization have a Nondiscrimination Policy? Does the organization have a Whistle Blower Policy? Does the organization have a Document Destruction Policy? CEO Comments The Chief Officers and Board of Directors of the Vanderbilt University Medical Center oversee the strategic management of the following areas: Fundraising Plan Strategic Plan Charitable Solicitations Management Succession/Training Plan Organizational Policies and Procedures Document Destruction 8

9 Financials Fiscal Year Fiscal Year Start July Fiscal Year End June Projected Revenue $22,040, Projected Expenses $25,246, Endowment Value $0.00 Endowment Spending Percentage (if selected) 0% Detailed Financials Revenue and Expenses Total Revenue $4,139,063,269 $3,820,125,123 $3,827,483,203 Total Expenses $3,908,725,873 $3,693,027,004 $3,653,388,442 Revenue Sources Foundation and Corporation $0 $0 $128,177,610 Contributions Government Contributions $341,718,783 $365,065,967 $375,304,754 Federal $0 $0 -- State $0 $0 -- Local $0 $0 -- Unspecified $341,718,783 $365,065,967 $375,304,754 Individual Contributions $119,951,783 $93,705, Indirect Public Support $0 $0 $0 Earned Revenue $3,218,704,557 $3,202,174,407 $3,131,309,587 Investment Income, Net of Losses $385,968,260 $108,328,279 $99,669,047 Membership Dues $0 $0 $0 Special Events $602,820 $702,773 $533,472 Revenue In-Kind $22,406,403 $17,077,708 $16,698,523 Other $49,710,663 $33,070,980 $62,508,714 9

10 Expense Allocation Program Expense $3,652,118,559 $3,444,667,221 $3,414,632,803 Administration Expense $224,688,734 $216,543,705 $206,252,116 Fundraising Expense $31,918,580 $31,816,078 $32,503,523 Payments to Affiliates $0 $0 -- Total Revenue/Total Expenses Program Expense/Total Expenses 93% 93% 93% Fundraising Expense/Contributed Revenue 7% 7% 6% Assets and Liabilities Total Assets $7,597,041,734 $7,437,841,959 $7,390,983,841 Current Assets $1,423,188,945 $1,587,793,537 $1,688,788,075 Long-Term Liabilities $1,342,963,341 $1,014,582,276 $1,744,320,380 Current Liabilities $918,831,773 $1,424,953,158 $574,841,909 Total Net Assets $5,335,246,620 $4,998,306,525 $5,071,821,552 Short Term Solvency Current Ratio: Current Assets/Current Liabilities Long Term Solvency Long-Term Liabilities/Total Assets 18% 14% 24% Top Funding Sources Top Funding Source & Dollar Amount Program Service Revenue $3,218,704,557 Program Service Revenue (Earned) $3,202,174, Second Highest Funding Source & Dollar Investment Income Government Grants -- Amount $385,968,260 $365,065,967 Third Highest Funding Source & Dollar Amount Government Grants $341,718,783 Investment Income/Sale of Assets $108,328, Capital Campaign Is the organization currently conducting a Capital Campaign for an endowment or the purchase of a major asset? No Capital Campaign Goal $0.00 Capital Campaign Anticipated in Next 5 Years? No State Charitable Solicitations Permit TN Charitable Solicitations Registration Exempt - Expires 0 Organization Comments The Chief Officers and Board of Directors of the Vanderbilt University Medical Center oversee the strategic management of the following areas: Endowment Fund Capital Campaign 10

11 GivingMatters.com Financial Comments * figures imported from GuideStar.org. **Income and Expense projections are for the Vanderbilt Transplant Center specifically. Financial figures taken from Vanderbilt University's 990.Financial documents prepared by PricewaterhouseCoopers, LLP.Comments provided by Laurel Fisher 8/8/14. Created Copyright 2018 The Community Foundation of Middle Tennessee 11